News for Amicus Therapeutics, Inc. (FOLD.MX)

Summary Amicus Therapeutics Inc (FOLD) announced on June 3, 2025, the publication of a post-hoc analysis from the PROPEL study in the journal "Muscle and Nerve.

Amicus Therapeutics (FOLD) has unveiled a publication detailing a post-hoc analysis from the PROPEL study, focusing on adults with late-onset Pompe disease. Thi

PRINCETON, N.J., June 03, 2025 (GLOBE NEWSWIRE) -- Amicus Therapeutics ( FOLD), today announced the publication of a post-hoc analysis of data from the ERT-e

Summary Amicus Therapeutics Inc (FOLD), a global biotechnology company dedicated to developing innovative medicines for rare diseases, announced on May 30, 2025

On May 16, 2025, Redmile Group, LLC (Trades, Portfolio) executed a notable transaction involving Atara Biotherapeutics Inc. The firm added 263,506 shares of Ata

We recently published a list of 10 Best Low Priced Biotech Stocks to Buy Now. In this article, we are going to take a look at where Amicus Therapeutics, Inc.

In a recent update, UBS analyst Karl Chalabala has maintained a \

Amicus Therapeutics, Inc. (NASDAQ:FOLD) Q1 2025 Earnings Conference Call May 1, 2025 8:30 AM ETCompany ParticipantsAndrew Faughnan - Vice President of...

Revenue: $125.2 million for Q1 2025, falling short of the estimated $135.86 million, yet marking a 15% increase year-over-year at constant exchange rates.Earni

We recently published a list of 11 Best Guru Stocks to Buy According to Wall Street Analysts. In this article, we are going to take a look at where Amicus Therapeutics, Inc. (NASDAQ:FOLD) stands against other Guru stocks to invest in. Wall Street seems to be breathing a little easier after the initial panic over […]

Summary Amicus Therapeutics Inc (FOLD), a global biotechnology company dedicated to developing innovative medicines for rare diseases, has announced it will hos

We recently published a list of 10 Best Low Priced Growth Stocks To Invest In. In this article, we are going to take a look at where Amicus Therapeutics, Inc.

Low priced stocks usually fall under the small to mid-cap size category.

We recently published a list of 10 Best Low Cost Stocks to Buy According to Billionaires. In this article, we are going to take a look at where Amicus Therapeutics, Inc. (NASDAQ:FOLD) stands against other best low cost stocks to buy according to billionaires. Markets are wobbling, and panic is becoming the headline. At times […]

Amicus Therapeutics, Inc. shows strong revenue growth with Galafold & Pombiliti driving potential $1bn by 2028. Click for my updated look at FOLD stock.

We recently compiled a list of the 12 Stocks Under $10 With High Upside Potential. In this article, we are going to take a look at where Amicus Therapeutics, Inc.

Significant Transaction by PERCEPTIVE ADVISORS LLC (Trades, Portfolio) On January 8, 2025, PERCEPTIVE ADVISORS LLC (Trades, Portfolio) executed a noteworthy tra

Amicus Therapeutics Inc (FOLD), a global biotechnology company dedicated to developing treatments for rare diseases, announced on February 27, 2025, that its ma

We recently published a list of the 10 Oversold Pharma Stocks to Buy According to Analysts. In this article, we are going to take a look at where Amicus Therapeutics, Inc.